Market Tracker

09/01 6:05pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

10.09
Data as of Aug 29
 +0.07 / +0.70%
Today’s Change
7.38
Today|||52-Week Range
10.21
+19.55%
Year-to-Date

Today’s Trading

Previous close10.02
Today’s open10.07
Day’s range9.97 - 10.09
Volume1,578,326
Average volume (3 months)2,282,258
Market cap$1.6B
Dividend yield5.95%
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+24.10%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio6.0
Price/Sales2.66
Price/Book12.44

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc-0.19-0.40%
MDCOMedicines Co+0.36+1.43%
RAREUltragenyx Pharmaceu...-0.51-0.95%
IPXLImpax Laboratories I...-0.01-0.04%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)$0.52
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts